Search
Skip to Search Results- 3Randomized controlled trials as topic
- 2Affect
- 2Cognition disorders (etiology; therapy)
- 2Dementia (complications)
- 2Depression (etiology; therapy)
- 2Phototherapy
-
Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia (Review)
Download2009
Forbes, D., Culum, I., Morgan, D.G., Forbes, J., Lischka, A.R., Forbes, S., Peacock, S.
Background Rest-activity and sleep-wake cycles are controlled by the endogenous circadian rhythmgenerated by the suprachiasmatic nuclei (SCN) of the hypothalamus. Degenerative changes in the SCN appear to be a biological basis for circadian disturbances in people with dementia, and might be...
-
2004
Morgan, D.G., Forbes, D., Bangma, J., Peacock, S., Adamson, J.
Background Rest-activity and sleep-wake cycles are controlled by the endogenous circadian rhythmgenerated by the suprachiasmatic nuclei (SCN) of the hypothalamus. Degenerative changes in the SCN appear to be a biological basis for circadian disturbances in people with dementia, and might be...
-
2005
Forbes, D., Morgan, D.G., Jansen, S.L., Duncan, V.
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to the clinical efficacy and safety of melatonin in the treatment of manifestations of dementia or cognitive impairment (CI).
-
2006
Duncan, V., Forbes, D., Malouf, R., Morgan, D.G., Jansen, S.L.
Background There are a number of studies that suggest a relationship between decline of melatonin function and the symptoms of dementia. Objectives The review assessed the evidence of clinical effectiveness of melatonin in the treatment of symptoms of dementia. Relevant primary outcomes were...